论文部分内容阅读
本文报告了利用癌性胸腹水淋巴细胞经N-IL 2进行LAK 诱导后回输治疗5例晚期恶性肿瘤。3例癌性胸水经治疗后,其中2例明显减少和消失。1例在观察期手术死亡。2例肝癌肝硬化腹水经治疗后腹水无明显改变,其中1例其它症状改善,腹水由血性变淡,淋巴细胞增加。此疗法适合于无产生漏出液因素所致的癌性胸腹水,以及在治疗前未进行大剂最化疗的患者。
This article reports the use of cancerous pleural and peritoneal lymphocytes transduced with N-IL 2 after LAK induction in the treatment of 5 advanced malignancies. After 3 cases of cancerous pleural effusion were treated, 2 of them significantly decreased and disappeared. One patient died during the observation period. Two cases of hepatocellular carcinoma liver cirrhosis ascites after treatment, no significant changes in the ascites, one of the other symptoms improved, ascites blood pale, lymphocytes increased. This therapy is suitable for cancerous hydrothorax and ascites caused by non-leakage factors, as well as patients who have not undergone large doses of chemotherapy before treatment.